机译:Alpha-1-抗胰蛋白酶单一疗法可降低实验性异体骨髓移植后的移植物抗宿主病
Department of Internal Medicine, University of Michigan Comprehensive Cancer Center, Ann Arbor, Ml 48109;
Department of Internal Medicine, University of Michigan Comprehensive Cancer Center, Ann Arbor, Ml 48109;
Faculty of Health Sciences, Ben-Gurion University of the Negev, Be'er Sheva 84105, Israel;
Department of Internal Medicine, University of Michigan Comprehensive Cancer Center, Ann Arbor, Ml 48109;
Department of Internal Medicine, University of Michigan Comprehensive Cancer Center, Ann Arbor, Ml 48109;
Department of Internal Medicine, University of Michigan Comprehensive Cancer Center, Ann Arbor, Ml 48109;
Department of Medicine, University of Colorado School of Medicine, Aurora, CO 80045;
Department of Medicine, University of Colorado School of Medicine, Aurora, CO 80045;
Department of Internal Medicine, University of Michigan Comprehensive Cancer Center, Ann Arbor, Ml 48109;
机译:结合Nifuroxazide和SAT05F疗法减少了实验同种异体骨髓移植后的移植物 - - 症状疾病
机译:适应性血红素加氧酶-1的诱导可改善实验性同种异体骨髓移植后的存活率并降低移植物抗宿主病。
机译:骨髓移植术患者患者降低强度条件下调主要组织相容性复杂匹配鼠同种异体造血细胞移植
机译:抗胸腺细胞球蛋白(ATG-Fresenius)预防无关供体骨髓移植的小儿和成年患者的急性和慢性移植物抗宿主病
机译:异体骨髓移植后针对移植物抗宿主病的抗原特异性诱导T调节细胞疗法。
机译:Alpha-1-抗胰蛋白酶单一疗法可降低实验性异体骨髓移植后的移植物抗宿主病
机译:Alpha-1-Anti rydsin单疗法在实验同种异体骨髓移植后减少移植物与宿主病